Moberg Pharma AB (publ) - ESG Rating & Company Profile powered by AI
This page contains a questions and answers section on Moberg Pharma AB (publ). This report of Moberg Pharma AB (publ) was assembled by All Street Sevva using advanced machine learning. Comprehensive Sustainability analysis of Moberg Pharma AB (publ) can be reached by signing in.
Moberg Pharma AB (publ) in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.5; made up of an environmental score of 0.0, social score of 6.4 and governance score of 4.0.
3.5
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1575 | Vitality Biopharma Inc | 3.6 | Medium |
| 1575 | Zhejiang East Asia Pharmaceutical Co Ltd | 3.6 | Medium |
| 1617 | Moberg Pharma AB (publ) | 3.5 | Medium |
| 1617 | Anika Therapeutics Inc | 3.5 | Medium |
| 1617 | Aerovate Therapeutics Inc | 3.5 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Moberg Pharma AB (publ) have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose current and historical energy intensity?
Sign up for free to unlockDoes Moberg Pharma AB (publ) report the average age of the workforce?
Sign up for free to unlockDoes Moberg Pharma AB (publ) reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose its ethnicity pay gap?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose cybersecurity risks?
Sign up for free to unlockDoes Moberg Pharma AB (publ) offer flexible work?
Sign up for free to unlockDoes Moberg Pharma AB (publ) have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Moberg Pharma AB (publ) conduct supply chain audits?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Moberg Pharma AB (publ) conduct 360 degree staff reviews?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose the individual responsible for D&I?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose water use targets?
Sign up for free to unlockDoes Moberg Pharma AB (publ) have careers partnerships with academic institutions?
Sign up for free to unlockDid Moberg Pharma AB (publ) have a product recall in the last two years?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose incidents of discrimination?
Sign up for free to unlockDoes Moberg Pharma AB (publ) allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Moberg Pharma AB (publ) issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose parental leave metrics?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose the pay ratio of women to men?
Sign up for free to unlockDoes Moberg Pharma AB (publ) support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Moberg Pharma AB (publ) reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Moberg Pharma AB (publ) involved in embryonic stem cell research?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose its waste policy?
Sign up for free to unlockDoes Moberg Pharma AB (publ) report according to TCFD requirements?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose energy use targets?
Sign up for free to unlockDoes Moberg Pharma AB (publ) disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Moberg Pharma AB (publ) have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Moberg Pharma AB (publ)
These potential risks are based on the size, segment and geographies of the company.
Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products in Europe, the United States, and internationally. It develops MOB-015, which has completed Phase III clinical trial for the treatment of nail fungus. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is headquartered in Bromma, Sweden.